Fundz

Fundz Deep Dive

Everything you need to win Inspire Medical Systems — in one platform.

Who to reach, what to say, and why now on Inspire Medical Systems — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Inspire Medical Systems — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Inspire Medical Systems, Inc. Announces $75 million Accelerated Share Repurchase Program

Nov 11, 2024•over 1 year ago

Contract Type

agreement

MinneapolisBiotechnologyHealth CareMedicalMedical Device

Description

Inspire Medical Systems, Inc. has announced an accelerated share repurchase (ASR) transaction under an agreement with Goldman Sachs & Co. LLC to repurchase an aggregate of $75.0 million of shares of the Company’s common stock. The ASR transaction is scheduled to terminate in the first quarter of 2025.

Company Information

Company

Inspire Medical Systems

Location

Minneapolis, Minnesota, United States

About

Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. The company's proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Inspire Medical Systems's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.